Framework Ventures IV L.P. - 16 Jan 2026 SCHEDULE 13D/A Report for NovaBay Pharmaceuticals, Inc. Common Stock, $0.01 par value (NBY)

Filing Manager
Framework Ventures IV L.P.
Reporting Manager
Framework Ventures IV L.P.
Security
NovaBay Pharmaceuticals, Inc. Common Stock, $0.01 par value
Symbol
NBY
Shares outstanding
126,235,733 shares
Disclosed Ownership
56,806,080 shares
Ownership
45%
Form type
SCHEDULE 13D/A
Filing time
21 Jan 2026, 20:12:44 UTC
Date of event
16 Jan 2026
Previous filing
20 Oct 2025
SEC
View on sec.gov

Reporting Managers (5)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Framework Ventures IV L.P. 45% 56,806,080 0 56,806,080 /s/ Michael Ernest Anderson Michael Ernest Anderson / Authorized Signatory 0002028474
Framework Ventures Management LLC 45% 56,806,080 0 56,806,080 /s/ Michael Ernest Anderson Michael Ernest Anderson / Authorized Signatory 0002091751
Framework Ventures IV GP LLC 45% 56,806,080 0 56,806,080 /s/ Michael Ernest Anderson Michael Ernest Anderson / Authorized Signatory 0002092591
Spencer Vance 45% 56,806,080 0 56,806,080 /s/ Vance Spencer Vance Spencer 0002092030
Anderson Michael Ernest 45% 56,806,080 0 56,806,080 /s/ Michael Ernest Anderson Michael Ernest Anderson 0002093174